Show Summary Details
Page of

Adaptive immunity in critical illness 

Adaptive immunity in critical illness
Adaptive immunity in critical illness

Sean F. Monaghan

and Alfred Ayala

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2022. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 16 May 2022

The development of sepsis remains a significant morbid event facing the critically-ill/severely-injured patient and while substantial improvements in supportive care have been made, a true molecular pharmacological treatment directed at mitigating the development of this condition has remained elusive. This is due, at least in part, to our lack of appreciation of the complex and intertwined changes in the nature of not only the innate, but also the adaptive immune response and how they affect our response to septic challenge. Here, we consider some of the aspects of the adaptive immune response, how it changes in the response to sepsis, possible pathological processes contributing to patient/experimental animal susceptibility to poorer outcomes and where novel immune-therapeutic targets/biomarkers may exist.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.